A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...
Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
Scientists at the University of Rochester pulled off a remarkable experiment: they transferred a longevity-related gene from ...
Gene Simmons reflected on the ‘horrible’ death of former Kiss bandmate Ace Frehley who died at age 74 from a stroke and a ...
The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
Dr. Marty Makary noted it had "record speed approval," the fastest approval of any gene therapy device combination in U.S.
Gene Simmons has added a seven-date Canadian tour to his increasingly busy 2026 plans. The Kiss star and his solo band will ...
Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both pediatric and adult patients after positive results.
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results